Predictive Oncology, a Nasdaq-listed company, announced plans to raise approximately $344 million through two private investment public equity transactions to support the launch of the Aethir (ATH) treasury. It is reported that DNA Holdings Venture, Inc. will serve as a strategic advisor to the digital currency treasury and a financial advisor to the company's digital assets.
纳斯达克上市公司Predictive Oncology宣布拟通过两笔私人投资公开股权交易配股募资约3.44亿美元以支持推出Aethir (ATH)财库,据悉DNA Holdings Venture, Inc. 将担任数字货币财库战略顾问和公司数字资产财务顾问。